Abivax (ABVX) Income towards Parent Company (2022 - 2026)

Abivax's Income towards Parent Company history runs 5 years deep, the most recent figure standing at -$56.2 million for Q1 2026.

• In Q1 2026, Income towards Parent Company fell 2.04% year-over-year to -$56.2 million; the TTM figure through Mar 2026 stood at -$372.2 million (down 86.54% YoY), while the FY2025 annual figure was -$377.7 million, down 100.62% from the prior year.
• Income towards Parent Company for Q1 2026 stood at -$56.2 million, up from -$81.9 million in the prior quarter.
• The five-year high for Income towards Parent Company was -$41.8 million in Q2 2024, with the low at -$179.3 million in Q3 2025.
• The 5-year median for Income towards Parent Company is -$56.2 million (2026), against an average of -$74.7 million.
• The sharpest annual moves came in 2024 and 2025: Income towards Parent Company jumped 69.33% in 2024, then sank 195.6% in 2025.
• Abivax's Income towards Parent Company stood at -$66.1 million in 2022, then plunged by 107.34% to -$137.1 million in 2023, then surged by 69.33% to -$42.0 million in 2024, then slumped by 94.84% to -$81.9 million in 2025, then soared by 31.37% to -$56.2 million in 2026.
• Business Quant data shows ABVX's Income towards Parent Company at -$56.2 million in Q1 2026, -$81.9 million in Q4 2025, and -$179.3 million in Q3 2025.